COMMUNIQUÉS West-GlobeNewswire

CJ Biomaterials Secures BPI, TÜV AUSTRIA Certifications for New PHACT™ All-PHA Compound Designed for Home Compostable Cutlery
30/09/2026
PHACT™ CB0104A earned BPI Commercial and Home Compostable, TÜV AUSTRIA OK compost HOME & OK compost INDUSTRIAL Certifications New all-PHA compound is designed for cutlery, caps, enclosures, beauty packaging, and [...]
ALK expands strategic tablet supply partnership with Catalent
30/09/2026
Inside Information Agreement provides long-term expanded access to Catalent's fast-dissolving (Zydis ® ) tablet formulation technology. Supply robustness secured with prioritised manufacturing capacity increase of ~40% [...]
SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity
30/09/2026
RANCHO CORDOVA, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a comprehensive five-year, more than $200 million investment plan to expand and upgrade its U.S. development and manufacturing [...]
Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026
30/09/2026
NESS ZIONA, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced it will [...]
Inteleos Earns UN ECOSOC Status to Advance Quality Care Worldwide
30/09/2026
Special Consultative Status expands Inteleos’ ability to build health equity through global partners and policy ROCKVILLE, Md., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The United Nations Economic and Social Council (ECOSOC) [...]
FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees
30/09/2026
Silver Spring, Md., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced a broad, nationwide recruitment effort to expand the range of qualified voices and perspectives on its [...]
Peptides Canada, Operated by Growth Guys, Announces Research-Use Peptide Supply Services for Canadian Laboratories
30/09/2026
TORONTO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Peptides Canada has announced the availability of research-use peptide materials through its online platform, providing Canadian laboratories and researchers with access to [...]
Native Path Collagen 2026: Launch Effective NativePath Collagen Peptides Dark Spots Bruising & Support for Skin, Hair, Joints & Bones Supplement Facts
30/09/2026
NativePath Collagen Peptides, a hydrolyzed Type I and III collagen supplement made from grass-fed bovine sources. Learn about its ingredients, formulation, and how collagen peptides are designed to complement daily [...]
UPDATE – Free Family Fun Night in Cedar Park: Ally Medical ER Ribbon Cutting
30/09/2026
EVENT UPDATE: Due to the flood watch in effect and the potential for severe weather, this event will be postponed . Please stay safe and keep an eye out for an updated date and time. The original release follows: CEDAR [...]
Flame Diet App Launches Personalized Anti-Inflammatory Diet
30/09/2026
Flame Diet App Turns a Short Quiz Into an Anti-Inflammatory Meal Plan and Light Workout Routine NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Flame Diet has launched a personalized anti-inflammatory diet and wellness app [...]
SK pharmteco annonce un investissement de plus de 200 millions de dollars aux États-Unis pour renforcer ses capacités de production de petites molécules et de peptides
30/09/2026
RANCHO CORDOVA, Californie, 30 sept. 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd’hui un plan d’investissement global de plus de 200 millions de dollars sur cinq ans destiné à étendre et à moderniser ses [...]
Two Lipidomics Excellence Awards Led to Two Major Publications
30/09/2026
Two recipients of Lipotype's Lipidomics Excellence Award have published award-supported lipid research at major scientific publications DRESDEN, Germany, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Lipotype introduced the [...]
Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner
30/09/2026
Fontaine Vitale represents a significant new market and revenue opportunity for Celularity in the Asia-Pacific region FLORHAM PARK, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” [...]
Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026
30/09/2026
JADE301 is designed to build on a clinically validated IFN-β mechanism with a differentiated profile designed for infrequent subcutaneous dosing JADE301 demonstrated high-affinity, selective IFN-β binding and greater [...]
Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection
30/09/2026
- Ribupatide injection (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg/m ² or higher - Topline data now expected in mid-2028 WALTHAM, Mass., Sept. 30, [...]
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
30/09/2026
– Rademikibart significantly reduced the rate of treatment failure compared to placebo through one month by 81% (p=0.0122) – – Rademikibart significantly reduced the rate of new moderate to severe COPD exacerbations [...]
10 Barrel Expands Salty Sips RTD Portfolio with New Blackberry Refresher
30/09/2026
Big Blackberry Flavor Meets Low-Sugar Refreshment in the New Salty Sips Easy-Drinking Vodka Cocktail BEND, Ore., Sept. 30, 2026 (GLOBE NEWSWIRE) -- 10 Barrel Brewing , the Bend-born craft beer brand known for bold beers [...]
Satellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy
30/09/2026
Data from BASECAMP expected in Q1 2027 TORONTO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to [...]
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
30/09/2026
SINGAPORE and NORTH BRUNSWICK, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Group Ltd. (NASDAQ: ANL) (“Adlai Nortye” or the “Company”), a clinical-stage biotechnology company focused on the development of [...]

Pages